The U.S. market for dental Bone graft substitutes and other biomaterials is growing in response to the growth of the dental implants market.
News & Features
Google released an open-source artificial intelligence tool that could help researchers turn vast amounts of DNA sequencing data into life-saving therapies and technologies.
Stryker has agreed to acquire Entellus Medical for about $662 million, a deal that would enhance the company's ear, nose, and throat device portfolio.
Takeda Pharmaceutical and Portal Instruments are teaming up to develop a new device to deliver drugs through a pressurized liquid, potentially eliminating the need for needle-based injections.
Just before the market closed on Wednesday, Edwards Lifesciences said it had acquired Harpoon Medical for $100 million, plus up to $150 million in pre-specified milestone payments over the next decade.
Five people who once worked at the hedge fund said Sam Isaly harassed female employees for years, according to an investigative report released this week. Though Isaly denied the allegations, OrbiMed said it has retained an independent law firm to investigate the matter, and called the incidents cited "concerning."
The agency is the first in the world to provide a comprehensive technical framework to advise manufacturers creating medical products on 3-D printers.
LivaNova has agreed to pony up $225 million to acquire ImThera Medical, less than a month after ditching the cardiac rhythm management business.
A molecular data company is developing a chip that leverages nanotechnology, optics, artificial intelligence, blockchain authentication, and edge computing to access and analyze molecular-level data in real time. The company says the technology will help redefine how global health challenges like superbugs, infectious diseases, and cancer are conquered.
These companies have risen above the rest in 2017. Which one do you think deserves to wear the crown?
The ideal medical device development team is co-located and multi-disciplined, but that’s not always the reality.
The CEO of Mazor Robotics is the subject of an insider trading probe in connection to a May 2016 deal with Medtronic, according to a report by an Israeli newspaper.
Australian researchers have developed a proof-of-concept of a wearable device that can predict the onset of seizures in patients with epilepsy.